Developer docs
API playgroundTry for free, no card

Search company profiles

Niconovum

Full company profile

uuid000fam8

Namestring
Niconovum
Legal namestring
Niconovum AB
Websiteurl
niconovum.se
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Niconovum AB is a Sweden-based specialty pharmaceutical company that develops and sells Nicotine Replacement Therapy (NRT) products under the Zonnic brand, targeting adults who want to quit or reduce their tobacco consumption. Founded in 2000 by Dr. Karl Olof Fagerström, a recognized authority on smoking cessation, the company was acquired by Reynolds American Inc. in 2009 and became a wholly-owned British American Tobacco subsidiary in 2017 following BAT's acquisition of RAI. Niconovum is headquartered in Malmö, Sweden, and operates with 11-50 employees.

The company's product portfolio consists of three 100% tobacco-free, regulated-medicine NRT formats: Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. Each format is offered in multiple strengths and is approved by relevant Medical Agencies based on safety, efficacy, and manufacturing processes. Manufacturing is performed by audited and licensed medical facilities in Sweden and France, and the products are positioned to deliver fast and long-lasting relief from nicotine cravings and withdrawal symptoms. There is no evidence in the input of proprietary software, AI/ML, or digital health components; the differentiators are clinical and regulatory rather than technological.

Niconovum generates revenue through three streams: branded Zonnic retail and e-commerce sales across four Nordic countries (Sweden, Norway, Finland, Iceland) via regional websites and physical retail; B2B private label NRT manufacturing for a major UK retailer; and licensing and in-licensing of NRT products and technology globally. The company pursues a direct-to-consumer and B2B model rather than platform or subscription economics, with no publicly disclosed pricing. As a wholly-owned BAT subsidiary, Niconovum functions as a strategic business unit within the parent's harm reduction portfolio rather than as an independent growth-stage company.

Short descriptiontext

Niconovum AB, a Malmö-based British American Tobacco subsidiary, develops and sells regulated, 100% tobacco-free Nicotine Replacement Therapy products (Zonnic Pouch, Mouth Spray, Lozenge) to adult consumers in the Nordics and through UK private label manufacturing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMalmö, Sweden
HQ citystring
Malmö
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nicotine replacement therapy, smoking cessation products, tobacco-free nicotine pouches, nicotine mouth spray, nicotine lozenges
Industry4 codes
PRIMARYCRADAMAI
Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAJAI
Nicotine Pouches (Tobacco-Free) Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
SECONDARYHLAIADAH
Smoking Cessation & Nicotine Replacement Therapy (NRT)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAJAM
Tobacco & Nicotine Contract Manufacturing & Private Label
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Nicotine Replacement Therapy (NRT) / Smoking Cessation Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Zonnic Brand Product Sales
TypeHardware Sales
Description

Direct consumer sales of branded NRT products (Zonnic Pouch, Mouth Spray, Lozenge) across Nordic markets (Sweden, Norway, Finland, Iceland) through retail channels and regional websites.

niconovum.se
2Private Label Manufacturing
TypeHardware Sales
Description

Manufactures private label NRT products for a major retailer in the UK, providing B2B revenue through contract manufacturing arrangements.

niconovum.se
3Licensing and In-licensing
TypeLicensing Royalties
Description

Pursues both out-licensing and in-licensing opportunities for NRT products and technology, generating revenue through intellectual property arrangements.

niconovum.se
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Zonnic
Description

Zonnic is the brand name for Niconovum's Nicotine Replacement Therapy products including Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. Products are 100% tobacco free and regulated medicines approved by Medical Agencies.

niconovum.se
Core offering1 text field

Niconovum develops, manufactures, and sells 100% tobacco-free Nicotine Replacement Therapy (NRT) products under the Zonnic brand in three delivery formats: Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. The company sells directly to consumers through retail/pharmacy channels and regional Zonnic e-commerce sites in Sweden, Norway, Finland, and Iceland, and also operates B2B private label contract manufacturing for a major UK retailer alongside out-licensing and in-licensing activities for NRT products and technology.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Niconovum offers a unified portfolio of Nicotine Replacement Therapy (NRT) products under the Zonnic brand name. The portfolio consists of three distinct product formats—Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge—all designed as 100% tobacco-free, regulated medical devices. These products provide consumers with options to meet personal tobacco reduction goals by delivering efficient and pleasant nicotine delivery. The company sells directly under the Zonnic brand across Sweden, Norway, Finland, and Iceland, while also manufacturing private-label NRT products for major UK retailers.

Product and service5 records
1Zonnic Pouch
CategoryNicotine Replacement Therapy
Description

A 100% tobacco-free nicotine pouch product that provides fast and long-lasting nicotine craving relief for adults over 18 looking to quit or reduce tobacco consumption. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.

2Zonnic Mouth Spray
CategoryNicotine Replacement Therapy
Description

A 100% tobacco-free fast-acting mouth spray nicotine replacement therapy that delivers rapid nicotine craving relief for adults over 18 looking to quit or reduce tobacco consumption. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.

3Zonnic Lozenge
CategoryNicotine Replacement Therapy
Description

A 100% tobacco-free lozenge nicotine replacement therapy product offering convenient and long-lasting nicotine craving relief in multiple strength options for adults over 18. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.

4Private Label NRT Manufacturing
CategoryContract Manufacturing
Description

B2B contract manufacturing of a private label Nicotine Replacement Therapy product for a major retailer in the UK. Produced by audited and licensed medical manufacturers in Sweden and France in compliance with regulatory standards.

5NRT Product and Technology Licensing
CategoryLicensing
Description

Out-licensing and in-licensing of Nicotine Replacement Therapy products and proprietary delivery technology to global partners, generating revenue through intellectual property arrangements.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Major UK Retailer
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Niconovum manufactures a private label NRT product for a major retailer in the UK, serving as a B2B manufacturing partner.

niconovum.se
Strategic tierCoreTypeTechnology or Integration
Description

All Zonnic products are produced by audited and licensed medical manufacturers in Sweden and France, ensuring compliance with regulatory standards for medicinal products.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Owner of the Nicorette and NicoDerm CQ brands, Haleon is the global category leader in NRT and the most direct competitor to Niconovum's Zonnic portfolio, with overlapping regulated NRT products sold across multiple geographies.

2Johnson & Johnson Consumer Health
TypeBroad incumbent
Description

Markets the Nicotinell NRT brand and operates a broad consumer health portfolio. Overlaps with Niconovum in regulated NRT (gum, patch, lozenge) and competes for the same consumer health retail and pharmacy shelf space.

TypeDirect peer
Description

A leading private label manufacturer of OTC NRT products for retailers in the US and Europe. Directly comparable to Niconovum on the B2B private label manufacturing side of the business, serving similar retailer customers.

TypeBroad incumbent
Description

Owns Swedish Match and the Zyn tobacco-free nicotine pouch brand. Competes in the same tobacco-free pouch category as Zonnic Pouch, though Zyn is positioned as a recreational product rather than a regulated NRT medicine.

TypeBroad incumbent
Description

Markets nicotine pouches (Skruf, ZoneX) and other modern oral nicotine products. Overlaps with Niconovum's Zonnic Pouch on format and consumer, though differentiated by regulatory classification.

TypeBroad incumbent
Description

Markets the Nordic Spirit tobacco-free nicotine pouch brand. A relevant adjacent competitor to Zonnic Pouch in the Nordic region, where Niconovum's core market overlaps with JTI's strongest pouch geography.

TypeEmerging player
Description

Manufactures and sells generic OTC NRT products (gum, lozenge) across multiple markets. Comparable to Niconovum in regulated NRT manufacturing capability and category focus, with greater geographic reach but less brand-led positioning.

8Fertin Pharma
TypeDirect peer
Description

A Danish contract manufacturer specializing in nicotine gum and other medicated chewing gum formats. Highly comparable to Niconovum on the B2B manufacturing side, serving similar pharma and consumer health customers in Europe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Niconovum

Nicotine Replacement Therapy (NRT) / Smoking Cessation Productsniconovum.se

Niconovum AB, a Malmö-based British American Tobacco subsidiary, develops and sells regulated, 100% tobacco-free Nicotine Replacement Therapy products (Zonnic Pouch, Mouth Spray, Lozenge) to adult consumers in the Nordics and through UK private label manufacturing.

What Niconovum does

Niconovum AB is a Sweden-based specialty pharmaceutical company that develops and sells Nicotine Replacement Therapy (NRT) products under the Zonnic brand, targeting adults who want to quit or reduce their tobacco consumption. Founded in 2000 by Dr. Karl Olof Fagerström, a recognized authority on smoking cessation, the company was acquired by Reynolds American Inc. in 2009 and became a wholly-owned British American Tobacco subsidiary in 2017 following BAT's acquisition of RAI. Niconovum is headquartered in Malmö, Sweden, and operates with 11-50 employees.

The company's product portfolio consists of three 100% tobacco-free, regulated-medicine NRT formats: Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. Each format is offered in multiple strengths and is approved by relevant Medical Agencies based on safety, efficacy, and manufacturing processes. Manufacturing is performed by audited and licensed medical facilities in Sweden and France, and the products are positioned to deliver fast and long-lasting relief from nicotine cravings and withdrawal symptoms. There is no evidence in the input of proprietary software, AI/ML, or digital health components; the differentiators are clinical and regulatory rather than technological.

Niconovum generates revenue through three streams: branded Zonnic retail and e-commerce sales across four Nordic countries (Sweden, Norway, Finland, Iceland) via regional websites and physical retail; B2B private label NRT manufacturing for a major UK retailer; and licensing and in-licensing of NRT products and technology globally. The company pursues a direct-to-consumer and B2B model rather than platform or subscription economics, with no publicly disclosed pricing. As a wholly-owned BAT subsidiary, Niconovum functions as a strategic business unit within the parent's harm reduction portfolio rather than as an independent growth-stage company.

Niconovum firmographics

Firmographics
Name
Niconovum
Legal name
Niconovum AB
Website
https://niconovum.se
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Niconovum AB, a Malmö-based British American Tobacco subsidiary, develops and sells regulated, 100% tobacco-free Nicotine Replacement Therapy products (Zonnic Pouch, Mouth Spray, Lozenge) to adult consumers in the Nordics and through UK private label manufacturing.
Ownership category
akta.pro rank

Niconovum industry classification

Industry
Product category
Nicotine Replacement Therapy (NRT) / Smoking Cessation Products
NAICS
Pharmaceutical and Medicine Manufacturing (32541)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRADAMAI
Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAJAI
Nicotine Pouches (Tobacco-Free) Manufacturing & Brands
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands
SECONDARYHLAIADAH
Smoking Cessation & Nicotine Replacement Therapy (NRT)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAJAM
Tobacco & Nicotine Contract Manufacturing & Private Label
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Tobacco & Nicotine Products Manufacturing & Brands

Keywords

  • Nicotine replacement therapy
  • Smoking cessation products
  • Tobacco-free nicotine pouches
  • Nicotine mouth spray
  • Nicotine lozenges

Where Niconovum is headquartered

Location

Headquarters

HQ city
Malmö
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Niconovum business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Zonnic Brand Product Sales: Direct consumer sales of branded NRT products (Zonnic Pouch, Mouth Spray, Lozenge) across Nordic markets (Sweden, Norway, Finland, Iceland) through retail channels and regional websites.
  2. Private Label Manufacturing: Manufactures private label NRT products for a major retailer in the UK, providing B2B revenue through contract manufacturing arrangements.
  3. Licensing and In-licensing: Pursues both out-licensing and in-licensing opportunities for NRT products and technology, generating revenue through intellectual property arrangements.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Niconovum product offering

Product offering

Core offering

Niconovum develops, manufactures, and sells 100% tobacco-free Nicotine Replacement Therapy (NRT) products under the Zonnic brand in three delivery formats: Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. The company sells directly to consumers through retail/pharmacy channels and regional Zonnic e-commerce sites in Sweden, Norway, Finland, and Iceland, and also operates B2B private label contract manufacturing for a major UK retailer alongside out-licensing and in-licensing activities for NRT products and technology.

Product overview

Niconovum offers a unified portfolio of Nicotine Replacement Therapy (NRT) products under the Zonnic brand name. The portfolio consists of three distinct product formats—Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge—all designed as 100% tobacco-free, regulated medical devices. These products provide consumers with options to meet personal tobacco reduction goals by delivering efficient and pleasant nicotine delivery. The company sells directly under the Zonnic brand across Sweden, Norway, Finland, and Iceland, while also manufacturing private-label NRT products for major UK retailers.

Differentiator

Problem solved

Functional benefit

Brands

  • Zonnic: Zonnic is the brand name for Niconovum's Nicotine Replacement Therapy products including Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. Products are 100% tobacco free and regulated medicines approved by Medical Agencies.

Products and services

  • Zonnic Pouch A 100% tobacco-free nicotine pouch product that provides fast and long-lasting nicotine craving relief for adults over 18 looking to quit or reduce tobacco consumption. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.
  • Zonnic Mouth Spray A 100% tobacco-free fast-acting mouth spray nicotine replacement therapy that delivers rapid nicotine craving relief for adults over 18 looking to quit or reduce tobacco consumption. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.
  • Zonnic Lozenge A 100% tobacco-free lozenge nicotine replacement therapy product offering convenient and long-lasting nicotine craving relief in multiple strength options for adults over 18. Sold as a regulated NRT medicine under the Zonnic brand across Nordic markets.
  • Private Label NRT Manufacturing B2B contract manufacturing of a private label Nicotine Replacement Therapy product for a major retailer in the UK. Produced by audited and licensed medical manufacturers in Sweden and France in compliance with regulatory standards.
  • NRT Product and Technology Licensing Out-licensing and in-licensing of Nicotine Replacement Therapy products and proprietary delivery technology to global partners, generating revenue through intellectual property arrangements.

Companies that use Niconovum

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles3 records

Niconovum technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Niconovum partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Major UK RetailercoreChannel Partner/ Reseller/ DistributorNiconovum manufactures a private label NRT product for a major retailer in the UK, serving as a B2B manufacturing partner.
  • Swedish and French Medical ManufacturerscoreTechnology or IntegrationAll Zonnic products are produced by audited and licensed medical manufacturers in Sweden and France, ensuring compliance with regulatory standards for medicinal products.

Scale indicators3 records

Recent moves8 records

Expansion highlights4 records

Niconovum competitors and assessment

Company assessment

Direct peers

  • Haleon: Owner of the Nicorette and NicoDerm CQ brands, Haleon is the global category leader in NRT and the most direct competitor to Niconovum's Zonnic portfolio, with overlapping regulated NRT products sold across multiple geographies.
  • Perrigo Company: A leading private label manufacturer of OTC NRT products for retailers in the US and Europe. Directly comparable to Niconovum on the B2B private label manufacturing side of the business, serving similar retailer customers.
  • Fertin Pharma: A Danish contract manufacturer specializing in nicotine gum and other medicated chewing gum formats. Highly comparable to Niconovum on the B2B manufacturing side, serving similar pharma and consumer health customers in Europe.

Broad incumbents

  • Johnson & Johnson Consumer Health: Markets the Nicotinell NRT brand and operates a broad consumer health portfolio. Overlaps with Niconovum in regulated NRT (gum, patch, lozenge) and competes for the same consumer health retail and pharmacy shelf space.
  • Philip Morris International (Swedish Match): Owns Swedish Match and the Zyn tobacco-free nicotine pouch brand. Competes in the same tobacco-free pouch category as Zonnic Pouch, though Zyn is positioned as a recreational product rather than a regulated NRT medicine.
  • Imperial Brands: Markets nicotine pouches (Skruf, ZoneX) and other modern oral nicotine products. Overlaps with Niconovum's Zonnic Pouch on format and consumer, though differentiated by regulatory classification.
  • Japan Tobacco International: Markets the Nordic Spirit tobacco-free nicotine pouch brand. A relevant adjacent competitor to Zonnic Pouch in the Nordic region, where Niconovum's core market overlaps with JTI's strongest pouch geography.

Emerging players

  • Dr. Reddy's Laboratories: Manufactures and sells generic OTC NRT products (gum, lozenge) across multiple markets. Comparable to Niconovum in regulated NRT manufacturing capability and category focus, with greater geographic reach but less brand-led positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Niconovum social profiles

Digital presence

Niconovum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Niconovum leadership team

Management profile

Number of profiles

Profiles1 record

Niconovum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Niconovum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Niconovum

What does Niconovum do?

Niconovum develops, manufactures, and sells 100% tobacco-free Nicotine Replacement Therapy (NRT) products under the Zonnic brand in three delivery formats: Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge. The company sells directly to consumers through retail/pharmacy channels and regional Zonnic e-commerce sites in Sweden, Norway, Finland, and Iceland, and also operates B2B private label contract manufacturing for a major UK retailer alongside out-licensing and in-licensing activities for NRT products and technology.

Is Niconovum a public or private company?

Niconovum is a private company. It is classified as corporate owned and is currently operating.

When was Niconovum founded?

Niconovum was founded in 2000. It employs 11 to 50 people.

Where is Niconovum based?

Niconovum is headquartered in Malmö, Sweden, in the Europe region.

How does Niconovum make money?

Three revenue lines are on record. Zonnic Brand Product Sales are the primary driver. The others are private Label Manufacturing and licensing and In-licensing.

Who are Niconovum's main competitors?

Direct peers on record are Haleon, Perrigo Company and Fertin Pharma. Broad incumbents are Johnson & Johnson Consumer Health, Philip Morris International (Swedish Match), Imperial Brands and Japan Tobacco International. Dr. Reddy's Laboratories is listed as an emerging player.

Does Niconovum have an API?

No public API is recorded for Niconovum.

What industry is Niconovum in?

Niconovum's product category is Nicotine Replacement Therapy (NRT) / Smoking Cessation Products. Its primary akta.pro industry code is CRADAMAI, Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges), with a secondary code of CRADAJAI, Nicotine Pouches (Tobacco-Free) Manufacturing & Brands. Its NAICS code is 32541 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales